Comparison Overview
Prothena AFFIRM-AL Amyloidosis Clinical Trial
Prothena AFFIRM-AL Amyloidosis Clinical Trial
331 Oyster Point Boulevard, San Francisco, 94080, US
Last Update: 14/01/2026
Prothena is a late-stage clinical biotechnology company with expertise in protein dysregulation and a diverse pipeline of novel investigational therapies for neurodegenerative and rare peripheral amyloid diseases.
Agilent Technologies
5301 Stevens Creek Boulevard, Santa Clara, 95051, US
Last Update: 01/04/2026
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them...
Compliance Ranges Comparison
Prothena AFFIRM-AL Amyloidosis Clinical Trial
Agilent Technologies
Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Prothena AFFIRM-AL Amyloidosis Clinical Trial in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Agilent Technologies in 2026.
Incident History - Prothena AFFIRM-AL Amyloidosis Clinical Trial (X = Date, Y = Severity)
Prothena AFFIRM-AL Amyloidosis Clinical Trial cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Agilent Technologies (X = Date, Y = Severity)
Agilent Technologies cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
Prothena AFFIRM-AL Amyloidosis Clinical Trial
Agilent Technologies
FAQ
Latest Global CVEs
A vulnerability was determined in Comfast CF-WR631AX V3 up to 2.7.0.8. Affected by this vulnerability is the function system_wl_upload_pic_file of the file /usr/bin/webmgnt of the component FastCGI Backend. This manipulation of the argument filename causes os command injection. It is possible to initiate the attack remotely. The exploit has been publicly disclosed and may be utilized. The vendor was contacted early about this disclosure but did not respond in any way.
A vulnerability was found in Leantime up to 3.8.0. Affected is the function Setting::saveSetting of the component API. The manipulation results in improper authorization. The attack may be performed from remote. The exploit has been made public and could be used. The vendor was contacted early about this disclosure but did not respond in any way.
A vulnerability has been found in Leantime up to 3.8.0. This impacts the function editUser/addUser of the component JSON-RPC Endpoint. The manipulation of the argument role leads to improper authorization. The attack is possible to be carried out remotely. The exploit has been disclosed to the public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.
A flaw has been found in Helicone ai-gateway up to 0.2.0-beta.30. This affects the function build_target_url of the file ai-gateway/src/dispatcher/service.rs of the component AWS Metadata Service. Executing a manipulation of the argument extracted_path_and_query can lead to server-side request forgery. The attack can be executed remotely. The exploit has been published and may be used. The vendor was contacted early about this disclosure but did not respond in any way.
A vulnerability was detected in coollabsio Coolify up to 4.1.1. The impacted element is an unknown function of the file /app/Policies/ of the component Policy Handler. Performing a manipulation results in missing authorization. Remote exploitation of the attack is possible. The exploit is now public and may be used.